These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4876210)

  • 1. [Research on the percent of positivity of the antiperinuclear factor in rheumatoid arthritis: correlation with some clinical and sere-immunological aspects].
    Damasio E; Rossi F; Viara M
    Reumatismo; 1967; 19(4):243-56. PubMed ID: 4876210
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical significance of the antinuclear factor determined by the immunofluorescent method in rheumatoid arthritis].
    Król W; Kolarzowska B
    Pol Tyg Lek; 1969 Mar; 24(11):399-400. PubMed ID: 4892175
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Study of 600 patients and meta-analysis of the literature.
    Berthelot JM; Garnier P; Glémarec J; Flipo RM
    Rev Rhum Engl Ed; 1998 Jan; 65(1):9-14. PubMed ID: 9523380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients].
    Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P
    Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis].
    Youinou P; Le Goff P; Miossec P; Moineau MP; Ferec C
    Z Rheumatol; 1983; 42(1):36-9. PubMed ID: 6189305
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic value of antikeratin antibodies in rheumatoid arthritis.
    Ordeig J; Guardia J
    J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinico-immunological study of serum and synovial fluid antinuclear factors in rheumatoid arthritis and other arthritides.
    MacSween RN; Dalakos TG; Jasani MK; Boyle JA; Buchanan WW; Goudie RB
    Clin Exp Immunol; 1968 Jan; 3(1):17-24. PubMed ID: 4171043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How useful are tests for rheumatoid factors, antiperinuclear factors, antikeratin antibody, and the HLA DR4 antigen for the diagnosis of rheumatoid arthritis?
    Saraux A; Valls I; Voisin V; Koreichi A; Baron D; Youinou P; Le Goff P
    Rev Rhum Engl Ed; 1995 Jan; 62(1):16-20. PubMed ID: 7540486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis].
    Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA
    Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antinuclear factors and rheumatoid arthritis].
    Jarlov NV
    Ugeskr Laeger; 1968 Sep; 130(38):1571-2. PubMed ID: 4882476
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
    Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
    J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-perinuclear antibodies in the diagnosis and prognosis of rheumatoid polyarthritis].
    Youinou P; Le Goff P; Miossec P; L'Hostis D; Pennec Y; Schwarzberg C; Ferrec C
    Rev Rhum Mal Osteoartic; 1983 May; 50(6):441-6. PubMed ID: 6351234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical importance of immunological parameters in rheumatoid polyarthritis].
    Peretz A; Mascart-Lemone F; Gaci O; Famaey JP
    Rev Med Brux; 1984 Nov; 5(9):597-600. PubMed ID: 6395257
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability of the antiperinuclear factor test despite the inconstancy of the targeted antigens.
    Youinou P; Le Goff P
    J Rheumatol; 1994 Nov; 21(11):1990-1. PubMed ID: 7869299
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of antinuclear antibodies in rheumatoid arthritis.
    Garcia-de la Torre I; Miranda-Mendez L
    J Rheumatol; 1982; 9(4):603-6. PubMed ID: 6182293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serology and immunoglobulin profile in rheumatoid arthritis.
    Adhya S; Chakraborty G; Hajra B; Bhattacharya S; Sikdar PK; Sinha S; Banerjee PP; Ghosh E; Chakraborty P
    Indian J Pathol Microbiol; 1998 Jan; 41(1):43-7. PubMed ID: 9581076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies with antinuclear activity in rheumatoid arthritis.
    Hrncír Z; Salavec M; Vanásek J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1973; 16(3):257-63. PubMed ID: 4606229
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antinuclear antibodies in patients with rheumatoid arthritis].
    Wranicz A; Budźko T
    Pol Tyg Lek; 1970 Oct; 25(42):1570-3. PubMed ID: 4920352
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K; Mueller-Eckhardt C; Becker W
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.